333 related articles for article (PubMed ID: 24457988)
1. Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer.
Han X; Yan S; Weijie Z; Feng W; Liuxing W; Mengquan L; Qingxia F
Cancer Gene Ther; 2014 Feb; 21(2):60-7. PubMed ID: 24457988
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-10b mediates TGF-β1-regulated glioblastoma proliferation, migration and epithelial-mesenchymal transition.
Ma C; Wei F; Xia H; Liu H; Dong X; Zhang Y; Luo Q; Liu Y; Li Y
Int J Oncol; 2017 May; 50(5):1739-1748. PubMed ID: 28393237
[TBL] [Abstract][Full Text] [Related]
3. MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.
Ma M; He M; Jiang Q; Yan Y; Guan S; Zhang J; Yu Z; Chen Q; Sun M; Yao W; Zhao H; Jin F; Wei M
Int J Biol Sci; 2016; 12(4):397-408. PubMed ID: 27019625
[TBL] [Abstract][Full Text] [Related]
4. miR-30d Blocked Transforming Growth Factor β1-Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells.
Ye Z; Zhao L; Li J; Chen W; Li X
Int J Gynecol Cancer; 2015 Nov; 25(9):1574-81. PubMed ID: 26501435
[TBL] [Abstract][Full Text] [Related]
5. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
6. KLF8 involves in TGF-beta-induced EMT and promotes invasion and migration in gastric cancer cells.
Zhang H; Liu L; Wang Y; Zhao G; Xie R; Liu C; Xiao X; Wu K; Nie Y; Zhang H; Fan D
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1033-42. PubMed ID: 23504025
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.
Wang H; Wu Q; Zhang Y; Zhang HN; Wang YB; Wang W
Cell Mol Biol Lett; 2017; 22():22. PubMed ID: 29118814
[TBL] [Abstract][Full Text] [Related]
9. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
Chen XB; Li W; Chu AX
J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
12.
Hu X; Li D; Zhan J; Yang C; Wang P; Meng X; Xu S; Che X; Xu L
DNA Cell Biol; 2024 May; 43(5):245-257. PubMed ID: 38489601
[TBL] [Abstract][Full Text] [Related]
13. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
[TBL] [Abstract][Full Text] [Related]
14. TET3 inhibits TGF-β1-induced epithelial-mesenchymal transition by demethylating miR-30d precursor gene in ovarian cancer cells.
Ye Z; Li J; Han X; Hou H; Chen H; Zheng X; Lu J; Wang L; Chen W; Li X; Zhao L
J Exp Clin Cancer Res; 2016 May; 35():72. PubMed ID: 27141829
[TBL] [Abstract][Full Text] [Related]
15. Targeting specificity protein 1 with miR-128-3p overcomes TGF-β1 mediated epithelial-mesenchymal transition in breast cancer: An in vitro study.
Nalla LV; Gondaliya P; Kalia K; Khairnar A
Mol Biol Rep; 2022 Jul; 49(7):6987-6996. PubMed ID: 35486287
[TBL] [Abstract][Full Text] [Related]
16.
Shin JM; Park JH; Yang HW; Moon JW; Lee HM; Park IH
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768968
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Linc00511 inhibits TGF-β-induced cell migration and invasion by suppressing epithelial-mesenchymal transition and down-regulating MMPs expression.
Jiang L; Xie X; Bi R; Ding F; Mei J
Biomed Pharmacother; 2020 May; 125():109049. PubMed ID: 32092827
[TBL] [Abstract][Full Text] [Related]
18. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells.
Kim S; Lee J; Jeon M; Nam SJ; Lee JE
Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
20. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
